EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer

Background: Epidermal growth factor receptor (EGFR) mutation testing is recommended in metastatic non-small cell lung cancer (NSCLC). The objective of this study was to assess changes in EGFR mutation testing patterns and tyrosine kinase inhibitor (TKI) use in US veterans with stage III-IV NSCLC bet...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Anna Hung, Kyung Min Lee, Patrick R. Alba, Yanhong Li, Anthony Z. Gao, Bradley J. Hintze, Olga V. Efimova, Rahul Shenolikar, Melissa Pavilack, Dan Simmons, Michael J. Kelley, Julie A. Lynch, Shelby D. Reed
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2021-01-01
Edice:	Cancer Treatment and Research Communications
Témata:	Cancer genomics Targeted drug therapy
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2468294221000265
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!